|
⚲
|
| Keyboard |
| Omega Fund VI GP LP | |
|---|---|
| Firm | Omega Fund Management LLC |
| Address | 185 Dartmouth Street Boston, MA 02116 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Omega Fund Management LLC | |||||
| Omega Fund VI LP | 021-325427 | Executive Officer | of 400.0 M |
188.8 M | |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Lexeo Therapeutics Inc LXEO
Series A convertible preferred stock · derivative
|
2023-11-07 | Conversion | 14,999,999 | ||
|
Lexeo Therapeutics Inc LXEO
Common Stock
|
2023-11-07 | Conversion | 1,415,865 | ||
|
Lexeo Therapeutics Inc LXEO
Common Stock
|
2023-11-07 | Conversion | 287,213 | ||
|
Lexeo Therapeutics Inc LXEO
Common Stock
|
2023-11-07 | Buy | 454,545 | $11.00 | 4,999,995 |
|
Lexeo Therapeutics Inc LXEO
Series B convertible preferred stock · derivative
|
2023-11-07 | Conversion | 2,615,533 | ||
|
Omega Alpha SPAC OMEG
Class A Ordinary Shares
|
2021-01-11 | Buy | 501,000 | $10.00 | 5,010,000 |
|
Spruce Biosciences Inc SPRB
Common Stock
|
2020-10-14 | Conversion | 1,911,022 | ||
|
Spruce Biosciences Inc SPRB
Common Stock
|
2020-10-14 | Buy | 250,000 | $15.00 | 3,750,000 |
|
Spruce Biosciences Inc SPRB
Series B Preferred Stock · derivative
|
2020-10-14 | Conversion | 12,500,000 | $0.00 |